Skip to main navigation Skip to search Skip to main content

Synthesis and TNF expression inhibitory properties of new thalidomide analogues derived via Heck cross coupling

  • Scott Stewart
  • , Daniel Spagnolo
  • , Marta Polomska
  • , M. Sin
  • , Mahdad Karimi
  • , Lawrence Abraham

Research output: Contribution to journalArticlepeer-review

Abstract

A library of new thalidomide analogues containing an olefin functionality were synthesised using a Heck cross coupling reaction from their aryl halogenated precursor. All analogues were tested for their ability to inhibit the synthesis of the proinflammatory cytokine Tumour Necrosis Factor (TNF). Compounds 22, 29, 33 and 37 were the most effective in this assay inhibiting TNF expression 50%, 69%, 52% and 50%, respectively. Crown copyright (c) 2007 Published by Elsevier Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)5819-5824
JournalBioorganic & medicinal chemistry letters
Volume17
Issue number21
DOIs
Publication statusPublished - 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Synthesis and TNF expression inhibitory properties of new thalidomide analogues derived via Heck cross coupling'. Together they form a unique fingerprint.

Cite this